Trial results for a study investigating a multilevel intervention to accelerate Colorectal Cancer screening and follow-up were posted on ClinicalTrials.gov on 2026-01-14. The study reported various participant counts for screening and ordering rates across two groups.
Background
Colorectal cancer (CRC) screening is crucial for early detection and prevention, as it allows for the identification and removal of precancerous polyps. Federally qualified health centers (FQHCs) serve a significant role in increasing CRC screenings among vulnerable populations. Beyond initial screening, timely and appropriate follow-up of abnormal results is essential to realize the full benefits of these cancer screenings. This study aimed to implement a multilevel intervention to enhance both screening and follow-up processes within these critical healthcare settings.
Trial design
This completed study, titled "Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up," enrolled 4 participants. The trial focused on the condition of Colorectal Cancer. The study's brief summary indicates its purpose was to implement a multilevel intervention to accelerate colorectal cancer screening and follow-up, particularly among vulnerable populations served by federally qualified health centers.
Key results
The trial reported several key measurements related to colorectal cancer screening rates and ordering rates:
- CRC Screening Rate:
- Group 1 reported participant counts of 8611, 9438, and 10720.
- Group 2 reported participant counts of 3989, 3186, and 3303.
- CRC Screening Ordering Rate:
- Group 1 reported participant counts of 7012, 6458, and 6478.
- Group 2 reported participant counts of 5087, 4757, and 4611.
What this means
The posted results provide specific participant counts for colorectal cancer screening and screening ordering rates within two distinct groups. These numbers reflect the observed scale of screening activities in the context of the implemented multilevel intervention. Without further details on the intervention components, baseline data, or comparative analyses, it is not possible to determine the intervention's impact or effectiveness from these raw counts alone. However, the data highlights the substantial number of individuals involved in screening efforts within the study's scope.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04514341, titled "Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up", were posted on 2026-01-14 on clinicaltrials.gov.